ロード中...
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
BACKGROUND: Chloroquine and hydroxychloroquine have been found to be efficient on SARS-CoV-2, and reported to be efficient in Chinese COV-19 patients. We evaluate the effect of hydroxychloroquine on respiratory viral loads. PATIENTS AND METHODS: French Confirmed COVID-19 patients were included in a...
保存先:
| 出版年: | Int J Antimicrob Agents |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Published by Elsevier B.V.
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7102549/ https://ncbi.nlm.nih.gov/pubmed/32205204 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijantimicag.2020.105949 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|